Medifoxamine (Cledial Gerdaxyl) is an antidepressant which acts as a dopamine reuptake inhibitor and agonist at the 5-HT2A and 5-HT2C receptors. It was used mainly in France but was withdrawn following problems with hepatotoxicity.
This page contains content from the copyrighted Wikipedia article "Medifoxamine"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
